Buscar resultados de ensayos clínicos
Autoimmune Hepatitis - 30 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis Condición: Autoimmune Diseases Fecha: 2016-02-28 Intervenciones: Biological: Regulatory T cells Regulatory t cells will be injected back to autoimmune hepatitis patients |
Not yet recruiting |
Nombre del estudio: Paeoniflorin Combination of Hepatoprotective Drugs Versus Hepatoprotective Drugs Only for Auto-immune Hepatitis Condición: Hepatitis, Autoimmune Fecha: 2016-08-09 Intervenciones:
|
Recruiting |
Nombre del estudio: Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Condición:
|
Recruiting |
Nombre del estudio: "Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics in Children" Condición:
Intervenciones: Drug: Metronidazole or Vancomycine Flagyl or Vancomycine x 14 days. |
Not yet recruiting |
Nombre del estudio: A Single-arm,Phase IIa,Safety and Efficacy Trial of Selected MSCs in the Treatment of Patients With PSC & AiH Condición:
Fecha: 2016-12-13 Intervenciones: Biological: Orbcel-C Selected Mesenchymal Stromal Cells derived from human ubmical cord |
Not yet recruiting |
Nombre del estudio: Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis Condición:
|
Recruiting |
Nombre del estudio: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Condición:
|
Completed |
Nombre del estudio: Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis Condición: Primary Sclerosing Cholangitis Fecha: 2010-03-12 Intervenciones: Drug: ursodeoxycholic acid (UDCA) Pediatric PSC patients already receiving UDCA therapy will enter a fou |
Recruiting |
Nombre del estudio: Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure Condición:
Fecha: 2012-02-24 Intervenciones: Drug: Ornithine phenylacetate Up to 36 patients will be en |
RECRUITING |
Nombre del estudio: A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) Condición: Autoimmune Hepatitis Fecha: 2024-05-18 Intervenciones: Subcutaneous injection of zetomipzomib with a target dose of 60 mg weekly |